Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives

Details for Australian Patent Application No. 2009237581 (hide)

Owner Reata Pharmaceuticals, Inc.

Inventors Greiner, Jack; Szucs, Stephen S.; Liu, Xiaofeng; Jiang, Xin; Visnick, Melean

Agent Pizzeys

Pub. Number AU-A-2009237581

PCT Pub. Number WO2009/129548

Priority 61/111,294 04.11.08 US; 61/046,366 18.04.08 US

Filing date 20 April 2009

Wipo publication date 22 October 2009

International Classifications

C07J 63/00 (2006.01) Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

11 November 2010 PCT application entered the National Phase

  PCT publication WO2009/129548 Priority application(s): WO2009/129548

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009237585-Novel therapeutical tools and methods for treating blindness

2009237579-Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17